Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             40 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 Abnormal B-cell development in TIMP-deficient bone marrow Weiss, Ashley

5 20 p. 3960-3974
artikel
2 Abnormalities of bone marrow B cells and plasma cells in primary immune thrombocytopenia Yu, Tian-shu

5 20 p. 4087-4101
artikel
3 Activation status dictates the function of unlicensed natural killer cells in mice and humans Aguilar, Ethan G.

5 20 p. 4219-4232
artikel
4 Adoptive T-cell therapy for Hodgkin lymphoma Ho, Carrie

5 20 p. 4291-4302
artikel
5 Altered microbiota-host metabolic cross talk preceding neutropenic fever in patients with acute leukemia Rashidi, Armin

5 20 p. 3937-3950
artikel
6 American Society of Hematology living guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19: May 2021 update on the use of intermediate-intensity anticoagulation in critically ill patients Cuker, Adam

5 20 p. 3951-3959
artikel
7 A new murine Rpl5 (uL18) mutation provides a unique model of variably penetrant Diamond-Blackfan anemia Yu, Lei

5 20 p. 4167-4178
artikel
8 A novel mechanism of thrombocytopenia by PS exposure through TMEM16F in sphingomyelin synthase 1 deficiency Fujii, Yoritaka

5 20 p. 4265-4277
artikel
9 Antagonism of inhibitors of apoptosis proteins reveals a novel, immune response-based therapeutic approach for T-cell lymphoma Ferrari, Nicola

5 20 p. 4003-4016
artikel
10 Anticoagulant therapy in patients with congenital FXI deficiency Bravo-Pérez, Carlos

5 20 p. 4083-4086
artikel
11 A phase 1/2 study of thiotepa-based immunochemotherapy in relapsed/refractory primary CNS lymphoma: the TIER trial Fox, Christopher P.

5 20 p. 4073-4082
artikel
12 A systematic review of the association between anti-β-2 glycoprotein I antibodies and APS manifestations Jiang, Debbie

5 20 p. 3931-3936
artikel
13 Blood–brain barrier permeability in survivors of immune-mediated thrombotic thrombocytopenic purpura: a pilot study Huang, Shih-Han Susan

5 20 p. 4211-4218
artikel
14 Blood transfusion trends in the United States: national inpatient sample, 2015 to 2018 Goel, Ruchika

5 20 p. 4179-4184
artikel
15 CD19-directed CAR T-cell therapy for treatment of primary CNS lymphoma Siddiqi, Tanya

5 20 p. 4059-4063
artikel
16 Comparison of haploidentical and umbilical cord blood transplantation after myeloablative conditioning Wagner Jr, John E.

5 20 p. 4064-4072
artikel
17 Comparison of 2-year outcomes with CAR T cells (ZUMA-1) vs salvage chemotherapy in refractory large B-cell lymphoma Neelapu, Sattva S.

5 20 p. 4149-4155
artikel
18 Editorial Board
5 20 p. i
artikel
19 Excellent response to very-low-dose radiation (4 Gy) for indolent B-cell lymphomas: is 4 Gy suitable for curable patients? Imber, Brandon S.

5 20 p. 4185-4197
artikel
20 Exogenous mitochondrial transfer and endogenous mitochondrial fission facilitate AML resistance to OxPhos inhibition Saito, Kaori

5 20 p. 4233-4255
artikel
21 Follicular lymphoma and macrophages: impact of approved and novel therapies Gouni, Sushanth

5 20 p. 4303-4312
artikel
22 Gata2 haploinsufficiency promotes proliferation and functional decline of hematopoietic stem cells with myeloid bias during aging Abdelfattah, Ali

5 20 p. 4285-4290
artikel
23 Genetic profiles of subcutaneous panniculitis-like T-cell lymphoma and clinicopathological impact of HAVCR2 mutations Koh, Jiwon

5 20 p. 3919-3930
artikel
24 Heterogeneous modulation of Bcl-2 family members and drug efflux mediate MCL-1 inhibitor resistance in multiple myeloma Bolomsky, Arnold

5 20 p. 4125-4139
artikel
25 Improved survival of patients with aggressive ATL by increased use of allo-HCT: a prospective observational study Ito, Ayumu

5 20 p. 4156-4166
artikel
26 Late-occurring venous thromboembolism in allogeneic blood or marrow transplant survivors: a BMTSS-HiGHS2 risk model Gangaraju, Radhika

5 20 p. 4102-4111
artikel
27 Long-term outcome of hyper-CVAD-R for Burkitt leukemia/lymphoma and high-grade B-cell lymphoma: focus on CNS relapse Samra, Bachar

5 20 p. 3913-3918
artikel
28 Multiparameter phenotyping of platelet reactivity for stratification of human cohorts Dunster, Joanne L.

5 20 p. 4017-4030
artikel
29 Next-generation sequencing–based monitoring of circulating tumor DNA reveals clonotypic heterogeneity in untreated PTCL Miljkovic, Milos D.

5 20 p. 4198-4210
artikel
30 Nonrelapse mortality among patients diagnosed with chronic GVHD: an updated analysis from the Chronic GVHD Consortium DeFilipp, Zachariah

5 20 p. 4278-4284
artikel
31 Outcomes of patients with CLL sequentially resistant to both BCL2 and BTK inhibition Lew, Thomas E.

5 20 p. 4054-4058
artikel
32 Platelet binding to polymerizing fibrin is avidity driven and requires activated αIIbβ3 but not fibrin cross-linking Buitrago, Lorena

5 20 p. 3986-4002
artikel
33 Platelet variability index: a measure of platelet count fluctuations in patients with immune thrombocytopenia Li, Na

5 20 p. 4256-4264
artikel
34 Population pharmacokinetic modeling of factor concentrates in hemophilia: an overview and evaluation of best practice Goedhart, Tine M.H.J.

5 20 p. 4314-4325
artikel
35 Pregnancy in women with an inferior vena cava filter: a tertiary center experience and overview of the literature Bistervels, Ingrid M.

5 20 p. 4044-4053
artikel
36 Therapy-related myeloid neoplasms in 109 patients after radiation monotherapy Patel, Anand Ashwin

5 20 p. 4140-4148
artikel
37 TLR7 ligation augments hematopoiesis in Rps14 (uS11) deficiency via paradoxical suppression of inflammatory signaling Peña, Oscar A.

5 20 p. 4112-4124
artikel
38 Transfusion of target antigens to preimmunized recipients: a new mechanism in transfusion-related acute lung injury Bayat, Behnaz

5 20 p. 3975-3985
artikel
39 Treatment of allosensitized patients receiving allogeneic transplantation Ciurea, Stefan O.

5 20 p. 4031-4043
artikel
40 Why is AAV FVIII gene therapy not approved by the US Food and Drug Administration yet? Arruda, Valder R.

5 20 p. 4313
artikel
                             40 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland